CareDx to Participate in Upcoming Investor Conferences

Rhea-AI Summary

CareDx (Nasdaq: CDNA), known as 'The Transplant Company,' has announced its participation in two upcoming investor conferences. The company's management will present at the Jefferies Global Healthcare Conference on June 6, 2023, at 11:30 AM PT / 2:30 PM ET and the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2023, at 1:00 PM PT / 4:00 PM ET. These events provide opportunities for CareDx to discuss its precision medicine solutions for transplant patients and caregivers with investors. Interested parties can listen to the webcasts via the Events & Presentations section of the CareDx Investor Relations website.

Positive

• CareDx's participation in high-profile conferences like Jefferies Global Healthcare and Goldman Sachs Annual Global Healthcare Conference can increase investor interest.
• Engaging with investors at these conferences provides a platform to showcase CareDx's precision medicine solutions, potentially attracting new investments.
• The scheduled presentations indicate active promotion of the company's latest advancements and strategic direction.

Negative

• The announcement lacks any specific new product launches or financial data updates, which might leave investors wanting more substantive information.
• No details on the potential financial impact or expected outcomes from participating in these conferences were provided.
• The absence of significant achievements or milestones in the PR could be seen as unremarkable by some investors.

BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA), The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in two upcoming investor conferences.

CareDx’s management is scheduled to present at the:

• Jefferies Global Healthcare Conference on Thursday, June 6, 2023, at 11:30 AM PT / 2:30 PM ET.
• Goldman Sachs 45^th Annual Global Healthcare Conference on Tuesday, June 11, 2023, at 1:00 PM PT / 4:00 PM ET.

To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredxinc.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240529027582/en/

CareDx, Inc.

Media Relations

Anna Czene

818-731-2203

aczene@caredx.com

Investor Relations

Greg Chodaczek

Investor@caredx.com

Source: CareDx, Inc.

FAQ

When will CareDx present at the Jefferies Global Healthcare Conference?

CareDx will present at the Jefferies Global Healthcare Conference on June 6, 2023, at 11:30 AM PT / 2:30 PM ET.

What time is CareDx's presentation at the Goldman Sachs 45th Annual Global Healthcare Conference?

CareDx's presentation at the Goldman Sachs 45th Annual Global Healthcare Conference is scheduled for June 11, 2023, at 1:00 PM PT / 4:00 PM ET.

How can I listen to CareDx's conference presentations?

You can listen to the webcasts of CareDx's conference presentations by visiting the Events & Presentations section of the CareDx Investor Relations website.

What company ticker symbol does CareDx use?

CareDx uses the ticker symbol CDNA on Nasdaq.

What is CareDx's focus in precision medicine?

CareDx focuses on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.